The aim of this study was to detect the genetic alterations in the Factor 8 gene in 26 patients from Western Algeria. We detected the presence of "intron 22 inversion" with long-range polymerase chain reaction (PCR). Negative patients for this inversion were analyzed for "intron 1 inversion" using multiplex PCR. Patients who were negative for both inversions were analyzed using a direct sequencing. Deleterious effects of novel mutations on protein were assayed with bioinformatics tools. Causing mutations were identified in 85.71% of the families, including 11 "intron 22 inversion," 1 "intron 1 inversion," and 6 different point mutations (2 nonsense, 1 splice site, and 3 missense mutations). Among these mutations, c.2189G > A (p.Cys711Tyr) and c.5219+1G>T are novel. This is the first study that reports spectrum of mutations in the Factor 8 gene in the Western Algerian population. Knowledge of these mutations is important for genetic counseling and medical care of affected families.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/1076029613513321 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mutational Profile in Romanian Patients with Hemophilia A.
Int J Mol Sci
July 2024
Hematology (Clinic and Laboratory) Discipline-Fundeni Clinical Institute, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Hemophilia A (HA) is an X-linked recessive bleeding disorder caused by mutations in the F8 gene, resulting in deficient or dysfunctional factor VIII (FVIII). This study aimed to characterize the mutational profile of HA in Romanian patients using next-generation sequencing (NGS) and multiplex ligation-dependent probe amplification (MLPA). A total of 107 patients were analyzed, revealing pathogenic or likely pathogenic variants in 96.
View Article and Find Full Text PDFLarge Intron Inversions in Romanian Patients with Hemophilia A-First Report.
Medicina (Kaunas)
October 2023
Department of Hematology and Bone Marrow Transplant, Fundeni Clinical Institute, 022328 Bucharest, Romania.
Article Synopsis
- Large intron inversions are a major genetic cause of severe hemophilia A, accounting for nearly 50% of cases worldwide, particularly in Romanian patients.
- In a study of 156 Romanian patients, intron 22 inversions were found in 41.7%, while intron 1 inversions were found in 3.2%, leading to a total of 44.9% with large intron inversions as the genetic defect.
- The research also indicates that patients with intron 1 inversion have a higher risk of developing inhibitors compared to those without any detected inversions.
[Application of Bionano-DNA Full-Length Optical Mapping Technology in Genetic Diagnosis of Hemophilia A Carriers].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
August 2023
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215007, Jiangsu Province, China, Dushu Lake Hospital Affiliated to Soochow University, Suzhou 215021, Jiangsu Province, China,E-mail:
Article Synopsis
- The study aims to use Bionano Saphyr full-length DNA optical mapping technology to improve the genetic diagnosis of women suspected to be carriers of hemophilia A but undetectable by standard methods.
- Two suspected female carriers were analyzed, revealing significant gene structure variations on their X chromosomes through optical mapping compared to a normal DNA reference.
- The findings indicate that this technology effectively identifies complex gene defects and could be crucial for prenatal and pre-pregnancy DNA testing for hemophilia carriers.
Spectrum of Causative Mutations in Patients with Hemophilia A in Russia.
Genes (Basel)
January 2023
Laboratory of Genetic Engineering of National Medical Research Center for Hematology, Novy Zykovski Lane 4a, 125167 Moscow, Russia.
Hemophilia A (HA) is one of the most widespread, X-linked, inherited bleeding disorders, which results from defects in the gene. Nowadays, more than 3500 different pathogenic variants leading to HA have been described. Mutation analysis in HA is essential for accurate genetic counseling of patients and their relatives.
View Article and Find Full Text PDF[Intron 1 and 22 inversions in factor VIII gene in patients with haemophilia A].
Zhonghua Xue Ye Xue Za Zhi
March 2009
Department of Hematology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, China.
Objective: To analyze intron 1 and 22 inversions in factor VIII (FVIII) gene in hemophilia A (HA) patients and and their families and to investigate the correlation between intron inversion and FVIII antibody.
Methods: All patients were detected FVIII: C and FVIII antibody. In addition, 81 unrelated HA patients were directly detected by multiplex PCR and long-distance PCR for intron 1 and 22 inversions in FVIII gene.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!